Simcere Innovation Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Simcere Innovation's estimated annual revenue is currently $4.3M per year.(i)
  • Simcere Innovation's estimated revenue per employee is $155,000

Employee Data

  • Simcere Innovation has 28 Employees.(i)
  • Simcere Innovation grew their employee count by 8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Simcere Innovation?

Simcere Innovation, Inc. located in Cambridge, MA, focuses on the research and development of life-changing therapies for our patients by utilizing cutting-edge technology, including cell and gene therapy. Simcere Innovation provides a remarkably unique model referred to as ?internal entrepreneurship?. This model combines research and development with open innovation between partnerships in an effective and creative fashion that fosters growth and success. Simcere Innovation is currently looking for outstanding scientists who aspire to become entrepreneurs with creative ideas and business plans. The internal entrepreneur will serve as an ?internal startup founder? responsible for leading his/her team to successfully complete various projects, while Simcere Innovation provides funding, infrastructure and other resources that are necessary for the completion of ongoing projects.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$4.3M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Simcere Innovation News

2022-04-17 - Proprietary SARS-CoV-2 3CL Inhibitor Rapidly Progressing in ...

HK), an innovation and R&D driven pharmaceutical company in China held ... Simcere has marketed five innovative drugs in China and in 2021,...

2022-04-17 - GI Innovation sends prior application for Kosdaq listing

The company licensed out GI-101, an immunotherapy candidate, to Simcere Pharmaceutical Group, a Chinese pharmaceutical company, in 2019,...

2022-04-06 - SIMCERE PHARMA (HK.2096) to host 2022 R&D Day

HONG KONG, April 6, 2022 /PRNewswire/ -- SIMCERE PHARMA (HK.2096), an innovation and R&D-driven pharmaceutical company with a mission of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.8M28N/AN/A
#2
$4M28N/AN/A
#3
$2.7M28N/AN/A
#4
$2.8M28N/AN/A
#5
$35M28N/AN/A